KCM
Kynam Capital Management Portfolio holdings
AUM
$1.54B
1-Year Est. Return
74.72%
This Fund
S&P 500
1 Year Est. Return
+74.72%
AUM
$1.54B
AUM Growth
+$193M
(+14%)
Holding
40
Top Buys
| 1 | +$20.2M | |
| 2 | +$16M | |
| 3 | +$8.71M | |
| 4 |
Cullinan Oncology
CGEM
|
+$7.32M |
| 5 |
Alector
ALEC
|
+$3.55M |
Top Sells
| 1 | +$81.1M | |
| 2 | +$48.4M | |
| 3 | +$43.8M | |
| 4 |
enGene Therapeutics
ENGN
|
+$28.1M |
| 5 |
MBX
MBX Biosciences
MBX
|
+$25.8M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cogent Biosciences
COGT
$5.91B
| $219M | 14.26% |
6,165,223
-1,720,949
|
|
||
2
Vera Therapeutics
VERA
$2.89B
| $174M | 11.32% |
3,433,051
-594,749
|
|
||
3
Syndax Pharmaceuticals
SNDX
$1.95B
| $169M | 11.01% |
8,050,959
-469,041
|
|
||
4
Celldex Therapeutics
CLDX
$2.68B
| $161M | 10.51% |
5,943,180
-157,549
|
|
||
5
Vaxcyte
PCVX
$8.75B
| $135M | 8.78% |
2,922,335
-149,253
|
|
||
6
BioCryst Pharmaceuticals
BCRX
$2.26B
| $73.1M | 4.76% |
9,366,526
-23,744
|
|
||
7
Beam Therapeutics
BEAM
$3.26B
| $67.6M | 4.4% |
2,440,214
-77,433
|
|
||
8
Viridian Therapeutics
VRDN
$1.48B
| $45.8M | 2.98% |
1,470,541
-2,957,386
|
|
||
9
Tyra Biosciences
TYRA
$2.22B
| $41.1M | 2.68% |
1,564,492
-765,506
|
|
||
10
CG Oncology
CGON
$5.9B
| $39.3M | 2.56% |
945,830
-1,059,375
|
|
||
11
CytomX Therapeutics
CTMX
$997M
| $38.2M | 2.49% |
8,966,077
+5,319,574
|
|
||
12
Nurix Therapeutics
NRIX
$1.72B
| $37.4M | 2.43% |
1,970,357
-198,248
|
|
||
13
Wave Life Sciences
WVE
$1.39B
| $36.9M | 2.4% |
2,169,105
-2,390,948
|
|
||
|
14
Cullinan Oncology
CGEM
$838M
| $32.2M | 2.1% |
3,114,132
+811,960
|
|
||
15
Immunocore
IMCR
$1.52B
| $29.7M | 1.94% |
856,462
-152,805
|
|
||
|
MBX
16
MBX Biosciences
MBX
$1.6B
| $29.5M | 1.92% |
934,799
-1,065,201
|
|
||
17
KalVista Pharmaceuticals
KALV
$1B
| $29.2M | 1.9% |
1,810,954
+1,204,783
|
|
||
18
Apellis Pharmaceuticals
APLS
$5.23B
| $22.8M | 1.49% |
908,607
+100,000
|
|
||
|
DVAX
19
DELISTED
Dynavax Technologies
DVAX
| $21.2M | 1.38% |
1,375,632
-769,687
|
|
||
|
BNR
20
Burning Rock Biotech
BNR
$225M
| $20M | 1.31% |
994,883
|
|
||
21
Travere Therapeutics
TVTX
$3.7B
| $19.8M | 1.29% |
517,884
-431,843
|
|
||
22
Pharvaris
PHVS
$1.96B
| $17.8M | 1.16% |
640,395
-34,605
|
|
||
|
23
enGene Therapeutics
ENGN
$572M
| $13.5M | 0.88% |
1,492,898
-3,501,192
|
|
||
24
Relay Therapeutics
RLAY
$2.95B
| $12M | 0.78% |
1,424,259
-1,462,755
|
|
||
25
Biohaven
BHVN
$1.61B
| $7.94M | 0.52% |
+702,884
|
|